Genetic rat models of Parkinson's disease

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Welchko, Ryan M ^a   Lévêque, Xavier T ^a   Dunbar, Gary L ^b,c  

^a CENTRAL MICHIGAN UNIVERSITY   (United States)

^b Central Michigan University College of Medicine   (United States)

^c Field Neurosciences Institute St Mary's of Michigan   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A30P ALPHA SYNUCLEIN; ALPHA SYNUCLEIN; DOPAMINE TRANSPORTER; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LENTIVIRUS VECTOR; LEUCINE RICH REPEAT KINASE 2; PARKIN; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN;

ACCURACY; CORPUS STRIATUM; DISEASE COURSE; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; GENETIC LINKAGE; GENETIC MODEL; HUMAN; IDIOPATHIC DISEASE; MICROGLIA; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE ENDING; NEURITE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SUBSTANTIA NIGRA PARS COMPACTA; SYMPTOM; TRANSGENIC RAT; VIRUS RECOMBINANT;

EID: 84861044859     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/128356     Document Type: Review

References (28)

1. Dawson T. M., New animal (Pubitemid 32004742)
2. Spillantini M. G., Schmidt M. L., Lee V. M. Y., Trojanowski J. Q., Jakes R., Goedert M., Synuclein in Lewy bodies Nature 1997 388 6645 839 840
3. Cooper O., Hallett P., Isacson O., Using stem cells and iPS cells to discover new treatments for Parkinson's disease Parkinsonism Related Disorders 2012 18 supplement 1 S14 S16
4. Yamada M., Mizuno Y., Mochizuki H., Parkin gene therapy for -synucleinopathy: a rat model of Parkinson's disease Human Gene Therapy 2005 16 2 262 270 (Pubitemid 40344217)
5. Jakes R., Spillantini M. G., Goedert M., Identification of two distinct synucleins from human brain FEBS Letters 1994 345 1 27 32 (Pubitemid 24154659)
6. Polymeropoulos M. H., Higgins J. J., Golbe L. I., Johnson W. G., Ide S. E., Di Iorio G., Sanges G., Stenroos E. S., Pho L. T., Schaffer A. A., Lazzarini A. M., Nussbaum R. L., Duvoisin R. C., Mapping of a gene for Parkinson's disease to chromosome 4q21-q23 Science 1996 274 5290 1197 1199 (Pubitemid 26389286)
7. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L., Mutation in the -synuclein gene identified in families with Parkinson's disease Science 1997 276 5321 2045 2047 (Pubitemid 27443610)
8. Zarranz J. J., Alegre J., Gmez-Esteban J. C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atarés B., Llorens V., Gomez Tortosa E., Del Ser T., Muoz D. G., De Yebenes J. G., The new mutation, E46K, of -synuclein causes Parkinson and Lewy body dementia Annals of Neurology 2004 55 2 164 173 (Pubitemid 38166992)
9. Krger R., Kuhn W., Mller T., Woitalla D., Graeber M., Ksel S., Przuntek H., Epplen J. T., Schls L., Riess O., Ala30Pro mutation in the gene encoding -synuclein in Parkinson's disease Nature Genetics 1998 18 2 106 108
10. Perez R. G., Waymire J. C., Lin E., Liu J. J., Guo F., Zigmond M. J., A role for -synuclein in the regulation of dopamine biosynthesis Journal of Neuroscience 2002 22 8 3090 3099 (Pubitemid 35379198)
11. Lee F. J. S., Liu F., Pristupa Z. B., Niznik H. B., Direct binding and functional coupling of -synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB Journal 2001 15 6 916 926 (Pubitemid 32290778)
12. Kirik D., Rosenblad C., Burger C., Lundberg C., Johansen T. E., Muzyczka N., Mandel R. J., Bjrklund A., Parkinson-like neurodegeneration induced by targeted overexpression of -synuclein in the nigrostriatal system Journal of Neuroscience 2002 22 7 2780 2791 (Pubitemid 37465827)
13. Klein R. L., King M. A., Hamby M. E., Meyer E. M., Dopaminergic cell loss induced by human A30P -synuclein gene transfer to the rat substantia nigra Human Gene Therapy 2002 13 5 605 612 (Pubitemid 34264311)
14. Lo Bianco C., Ridet J. L., Schneider B. L., Déglon N., Aebischer P., Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2002 99 16 10813 10818
15. Yamada M., Iwatsubo T., Mizuno Y., Mochizuki H., Overexpression of -synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of -synuclein and activation of caspase-9: Resemblance to pathogenetic changes in Parkinson's disease Journal of Neurochemistry 2004 91 2 451 461 (Pubitemid 39363444)
16. Gorbatyuk O. S., Li S., Sullivan L. F., Chen W., Kondrikova G., Manfredsson F. P., Mandel R. J., Muzyczka N., The phosphorylation state of Ser-129 in human -synuclein determines neurodegeneration in a rat model of Parkinson disease Proceedings of the National Academy of Sciences of the United States of America 2008 105 2 763 768 (Pubitemid 351171782)
17. da Silveira S. A., Schneider B. L., Cifuentes-Diaz C., Sage D., Abbas-Terki T., Iwatsubo T., Unser M., Aebischer P., Phosphorylation does not prompt, nor prevent, the formation of -synuclein toxic species in a rat model of Parkinson's disease Human Molecular Genetics 2009 18 5 872 887
18. Recchia A., Rota D., Debetto P., Peroni D., Guidolin D., Negro A., Skaper S. D., Giusti P., Generation of a -synuclein-based rat model of Parkinson's disease Neurobiology of Disease 2008 30 1 8 18
19. Lelan F., Lescaudron L., Boyer C., Thinard R., Rémy S., Usal C., Tesson L., Anegon I., Neveu I., Damier P., Naveilhan P., Effects of human alpha-synuclein A53T-A30P mutations on SVZ and local olfactory bulb cell proliferation in a transgenic rat model of Parkinson disease Parkinson's Disease 2011 2011 11
20. Dusonchet J., Kochubey O., Stafa K., Young Jr. S. M., Zufferey R., Moore D. J., Schneider B. L., Aebischer P., A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2 Journal of Neuroscience 2011 31 3 907 912
21. Zhou H., Huang C., Tong J., Hong W. C., Liu Y. -J., Xia X. -G., Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake International Journal of Biological Sciences 2011 7 6 753 761
22. Sanchez-Guajardo V., Febbraro F., Kirik D., Romero-Ramos M., Microglia acquire distinct activation profiles depending on the degree of -synuclein neuropathology in a rAAV based model of Parkinson's disease PLoS One 2010 5 1
23. Lo Bianco C., Déglon N., Pralong W., Aebischer P., Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease Neurobiology of Disease 2004 17 2 283 289 (Pubitemid 39345783)
24. Decressac M., Ulusoy A., Mattsson B., Georgievska B., Romero-Ramos M., Kirik D., Bjrklund A., GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease Brain 2011 134 8 2302 2311
25. Lo Bianco C., Schneider B. L., Bauer M., Sajadi A., Brice A., Iwatsubo T., Aebischer P., Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an -synuclein rat model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2004 101 50 17510 17515 (Pubitemid 39657434)
26. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 1998 392 6676 605 608 (Pubitemid 28207717)
27. Taylor J. P., Mata I. F., Farrer M. J., LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? Trends in Molecular Medicine 2006 12 2 76 82 (Pubitemid 43202125)
28. Mata I. F., Ross O. A., Kachergus J., Huerta C., Ribacoba R., Moris G., Blazquez M., Guisasola L. M., Salvador C., Martinez C., Farrer M., Alvarez V., LRRK2 mutations are a common cause of Parkinson's disease in Spain European Journal of Neurology 2006 13 4 391 394